Patents/Inventors

Eric Smith

New York, NYUS77 patents

58 Patents

US126199952026
Detecting and Preventing Duplicate Transactions on a Transaction Exchange Platform
Capital One Services, LLC
0 cites
US126007802026
Anti-cd3 Antibodies, Bispecific Antigen-binding Molecules That Bind CD3 and CD20, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US125901682026
Antigen-binding Molecules That Bind CD38 And/or CD28, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US125773042026
Anti-cd3 Antibodies with Low Binding Affinity
Regeneron Pharmaceuticals, Inc.
0 cites
US125707642026
Anti-muc16 Antibodies, Antibody-drug Conjugates, and Bispecific Antigen-binding Molecules That Bind MUC16 and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US125670012026
Machine Learning Generation for Real-time Location
DENSO CORPORATION
0 cites
US125431432026
System and Method for Determining Location
DENSO CORPORATION
0 cites
US125288512026
Il2-based Therapeutics and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US125095162025
Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors
Regeneron Pharmaceuticals, Inc.
0 cites
US125095142025
Antibodies Comprising Chimeric Constant Domains
Regeneron Pharmaceuticals, Inc.
0 cites
US124643152025
System and Method for Establishing Real-time Location
DENSO CORPORATION
0 cites
US124418002025
Bispecific Anti-psma X Anti-cd28 Antibodies and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US124192822025
0 cites
US123917532025
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
USD10889362025
Bracelet
2050, LLC
0 cites
US123541562025
System and Method for Data Extraction
NCR Voyix Corporation
0 cites
US123446772025
Anti-psma Antibodies, Bispecific Antigen-binding Molecules That Bind PSMA and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US123311092025
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US123197242025
IL2 Agonists and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US122936282025
System and Method for Managing a Casino-style Battleships Game
0 cites
US122804842025
Post Driver
AOB Products Company
0 cites
US122747472025
Compositions and Methods for Treating Cytokine Release Syndrome
Regeneron Pharmaceuticals, Inc.
0 cites
US122678062025
Distributed Generation of Real-time Location
DENSO CORPORATION
0 cites
US122584122025
Nucleic Acid Molecules Encoding Bispecific Anti-bcma X Anti-cd3 Antibodies
Regeneron Pharmaceuticals, Inc.
0 cites
US122151312025
Igg Fc-il2-rα-il2 Fusions and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US122151482025
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US121807372024
Post Driver and Remover
AOB Products Company
0 cites
US121802722024
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US121651562024
Transaction Exchange Platform for Handling Returned Transactions
Capital One Services, LLC
0 cites
US121577582024
Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format
Regeneron Pharmaceuticals, Inc.
0 cites
US121557902024
Methods and Systems for Multiple Channel Authentication
United Services Automobile Association (USAA)
0 cites
US121342092024
Bulkhead System for Concrete Casting Bed
Conewago Manufacturing, LLC
0 cites
US121185672024
Detecting and Preventing Duplicate Transactions on a Transaction Exchange Platform
Capital One Services, LLC
0 cites
US121185662024
Removing Duplicate Transactions from a Transaction Exchange Platform
Capital One Services, LLC
0 cites
US120914402024
IL2 and Peptide-mhc Complex Fusion Proteins and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US120850662024
Pulsatile Fluid Pump System
Ventriflo, Inc.
0 cites
US120776032024
Multispecific Antigen-binding Molecules for Cell Targeting and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US120655082024
Multispecific Antigen-binding Molecules for Cell Targeting and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US120567132024
Transaction Exchange Platform with a Validation Microservice for Validating Transactions Before Being Processed
Capital One Services, LLC
0 cites
US120422372024
Surgical System with Voice Control
Cilag GmbH International
0 cites
US119797892024
System and Method for Establishing Real-time Location
DENSO CORPORATION
0 cites
US119726492024
System and Method for Communicating with a Vehicle
DENSO CORPORATION
0 cites
US119650202024
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US119524302024
Multispecific Antigen-binding Molecules for Cell Targeting and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US119375872024
0 cites
US119053322024
Antigen-binding Molecules That Bind CD38 And/or CD28, and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US118459322023
Compositions, Methods, Modules and Instruments for Automated Nucleic Acid-guided Nuclease Editing in Mammalian Cells via Viral Delivery
INSCRIPTA, Inc.
0 cites
US118208152023
Human Antibodies to Human Delta Like Ligand 4
Regeneron Pharmaceuticals, Inc.
0 cites
US118136482023
Firearm Bore Cleaner
AOB Products Company
0 cites
US117743282023
Homogenizer and Method of Grinding Large Sample Quantities
SPEX SAMPLEPREP, LLC
0 cites
US117507432023
Database Allocation and Analytics for Service Call Centers
United Services Automobile Association (“USAA”)
0 cites
US117250342023
IL2 Agonists and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US117084072023
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US116778702023
Methods and Systems for Multiple Channel Authentication
UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA)
0 cites
US116405782023
Break-based Inventory Forecasting
Xandr Inc.
0 cites
US116335012023
Anti-steap2 Antibodies, Antibody-drug Conjugates, and Bispecific Antigen-binding Molecules That Bind STEAP2 and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US115915922023
Compositions, Methods, Modules and Instruments for Automated Nucleic Acid-guided Nuclease Editing in Mammalian Cells Using Microcarriers
Inscripta, Inc.
0 cites
US115489472023
Bispecific Anti-psma X Anti-cd28 Antibodies and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites